CVE-2024-41668
cBioPortal Proxy Endpoint Vulnerabliity
- State
- Published
- Severity
- 8.3 High
- Published
- Jul 23, 2024
- Updated
- Aug 2, 2024
- Reserved
- Jul 18, 2024
Description
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
Scores
| CVSS | Score | Vector | Source |
|---|---|---|---|
| 3.1 | 8.3 High | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L | GitHub_M |
Weaknesses
- CWE-918 Server-Side Request Forgery (SSRF)
Affected Products
| Product | Versions |
|---|---|
cbioportalcBioPortal |
|
References
- https://github.com/cBioPortal/cbioportal/security/advisories/GHSA-9h44-r3c3-q7rm
- https://github.com/cBioPortal/cbioportal/pull/10884
- https://github.com/cBioPortal/cbioportal/commit/ea8642fdbda2d61d2ab34b9da7a1594680bbbcd5
- https://github.com/cBioPortal/cbioportal/releases/tag/v6.0.12
- https://www.wizlynxgroup.com/security-research-advisories/vuln/WLX-2024-004
Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.